Document is current
Any future updates will be listed below
-
Authors
Peters, Luisa
Krogmann, Amanda
von Hardenberg, Laura
Bödeker, Katja
Nöhles, Viktor B.
Correll, Christoph U.
- License Information
-
More Information
Article History
First Online: 19 November 2019
Compliance with Ethical Standards
:
: Luisa Peters, Amanda Krogmann, Laura von Hardenberg, Katja Bödeker, and Viktor B. Nöhles each declare no potential conflicts of interest. Christoph U. Correll has been a consultant and/or advisor to or has received honoraria from: Alkermes, Allergan, Angelini, Boehringer-Ingelheim, Gedeon Richter, Gerson Lehrman Group, Indivior, IntraCellular Therapies, Janssen/J&J, LB Pharma, Lundbeck, MedAvante-ProPhase, Medscape, Merck, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, Sumitomo Dainippon, Sunovion, Supernus, Takeda, and Teva. He has provided expert testimony for Bristol-Myers Squibb, Janssen, and Otsuka. He served on a Data Safety Monitoring Board for Boehringer-Ingelheim, Lundbeck, Rovi, Supernus, and Teva. He received royalties from UpToDate and grant support from Janssen and Takeda. He is also a shareholder of LB Pharma.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
